These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30693485)

  • 1. Effect of pembrolizumab on CD4
    Toor SM; Sasidharan Nair V; Pfister G; Elkord E
    Clin Exp Immunol; 2019 Jun; 196(3):345-352. PubMed ID: 30693485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
    Toor SM; Syed Khaja AS; Alkurd I; Elkord E
    Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.
    Drennan S; Stafford ND; Greenman J; Green VL
    Immunology; 2013 Nov; 140(3):335-43. PubMed ID: 23826668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway.
    Helling B; König M; Dälken B; Engling A; Krömer W; Heim K; Wallmeier H; Haas J; Wildemann B; Fritz B; Jonuleit H; Kubach J; Dingermann T; Radeke HH; Osterroth F; Uherek C; Czeloth N; Schüttrumpf J
    Immunol Cell Biol; 2015 Apr; 93(4):396-405. PubMed ID: 25512343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
    Han Y; Guo Q; Zhang M; Chen Z; Cao X
    J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Effector Phenotype of Tim-3
    Liu Z; McMichael EL; Shayan G; Li J; Chen K; Srivastava R; Kane LP; Lu B; Ferris RL
    Clin Cancer Res; 2018 Sep; 24(18):4529-4538. PubMed ID: 29712685
    [No Abstract]   [Full Text] [Related]  

  • 8. Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis.
    Chen ML; Yan BS; Bando Y; Kuchroo VK; Weiner HL
    J Immunol; 2008 Jun; 180(11):7327-37. PubMed ID: 18490732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
    Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
    Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.
    Bhattacharyya S; Md Sakib Hossain D; Mohanty S; Sankar Sen G; Chattopadhyay S; Banerjee S; Chakraborty J; Das K; Sarkar D; Das T; Sa G
    Cell Mol Immunol; 2010 Jul; 7(4):306-15. PubMed ID: 20305684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Providence of the CD25
    Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
    Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
    Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
    Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
    Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
    Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.
    Ebinuma H; Nakamoto N; Li Y; Price DA; Gostick E; Levine BL; Tobias J; Kwok WW; Chang KM
    J Virol; 2008 May; 82(10):5043-53. PubMed ID: 18337568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpopulations of bovine WC1(+) gammadelta T cells rather than CD4(+)CD25(high) Foxp3(+) T cells act as immune regulatory cells ex vivo.
    Hoek A; Rutten VP; Kool J; Arkesteijn GJ; Bouwstra RJ; Van Rhijn I; Koets AP
    Vet Res; 2009; 40(1):6. PubMed ID: 18928784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.